TABLE 3

Provider Counseling Strategies Used by Randomization Group

Low-Literacy Action Plan (n = 61), n (%)Standard Action Plan (n = 58), n (%)PaOR95% CI
Presentation of medication instructions
 How medication frequency described
  Flovent: morning and nightb59 (96.7)30 (51.7)<.00127.56.1–123.4
  Flovent: twice a day, 2×/day16 (26.2)45 (77.6)<.0010.10.04–0.2
  Singulair: every nightb54 (88.5)26 (44.8)<.0019.53.7–24.4
  Singulair: once a day, 1×/day7 (11.5)32 (55.2)<.0010.10.04–0.3
 Color of inhaler described
  Flovent (orange)b10 (16.4)5 (8.6).32.10.7–6.5
  Albuterol (blue)b10 (16.4)1 (1.7).0111.21.4–90.4
Presentation of spacer information
 Spacer use with Floventb50 (82.0)24 (41.4)<.0016.42.8–14.9
 Spacer use with Albuterolb51 (83.6)25 (43.1)<.0016.72.9–15.8
Reinforcement of need for everyday preventive medications, even when sick
 Mentions need to continue to give every day medicinesb57 (93.4)20 (34.5)<.00127.18.6–85.4
 Specifically names Floventb35 (57.4)11 (19.0)<.0015.82.5–13.2
 Specifically names Singulairb32 (52.5)12 (20.7).0014.21.9–9.5
Presentation of symptoms of serious exacerbation (red zone)
 Breathing fastb31 (50.8)5 (8.6)<.00111.03.9–31.2
 Breathing hardb24 (39.3)2 (3.4)<.00118.24.0–81.5
 Difficulty breathing25 (41.0)36 (62.1).030.40.2–0.9
 Cannot stop coughingb28 (45.9)1 (1.7)<.00148.46.3–372.0
 Coughing16 (26.2)19 (32.8).60.70.3–1.6
 Neck pulls inb29 (47.5)1 (1.7)<.00151.76.7–397.2
 Ribs show when breathingb33 (54.1)2 (3.4)<.00133.07.4–147.5
 Trouble talkingb36 (59.0)20 (34.5).012.71.3–5.8
 Trouble walking18 (29.5)15 (25.9).81.20.5–2.7
 Wheezing3 (4.9)17 (29.3)<.0010.10.03–0.5
  • a χ2.

  • b Aspects specifically supported by the low-literacy, pictographic action plan.